"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."

During the past decade, Johanniter-Kinderklinik conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johanniter-Kinderklinik" #1 sponsor was "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "University Hospital Schleswig-Holstein" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johanniter-Kinderklinik" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 3 trials as a collaborator and "Deutsche Kinderkrebsstiftung" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Johanniter-Kinderklinik" are "Juvenile Idiopathic Arthritis" (7 trials), "Neuroblastoma" (3 trials), "Leukemia" (2 trials), "Active Juvenile Psoriatic Arthritis" (1 trials) and "Acute Lymphoblastic Leukemia, Pediatric" (1 trials). Many other conditions were trialed in "Johanniter-Kinderklinik" in a lesser frequency.

Most popular intervention types in "Johanniter-Kinderklinik" are "Drug" (22 trials), "Radiation" (8 trials), "Biological" (6 trials), "Procedure" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ifosfamide" (6 trials), "vindesine" (6 trials), "carboplatin" (5 trials), "cyclophosphamide" (5 trials) and "doxorubicin hydrochloride" (5 trials). Other intervention names were less common.

The vast majority of trials in "Johanniter-Kinderklinik" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Johanniter-Kinderklinik". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Johanniter-Kinderklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Johanniter-Kinderklinik, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".